Paul T. Quinlan, General Counsel at CymaBay Therapeutics, Inc. (CBAY), sold 5,000 shares at $13.76 ($69K) on 2023-10-16, disclosed to the SEC on 2023-10-18.
Open-market sale of $69k CBAY by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ORKA | SELL | 2026-08-14 | $5.6M | — | Filing → |
| ORKA | SELL | 2026-06-15 | $51K | — | Filing → |
| ORKA | SELL | 2026-03-17 | $30K | — | Filing → |